Skip to Content

Clinical Trials Detail

Antenatal Late Preterm Steroids (ALPS) Ancillary Study: Genetic Variation, Response to Antenatal Steroids, and Late Preterm Morbidity

Objective

Examine the relationship between genetic factors, amounts of cord blood hormones and drug levels, and the development of medical problem in babies that are born three to six weeks early.

IRB Protocol Number
11-0628

All Other Trials

  • Pregnancy, Childbirth, and Newborn Care
Contact
Kathy Hale, RN at 303-724-6685
Eligibility and Other Participant Information

Enrolled in Antenatal Late Preterm Steroids (ALPS): Randomized Placebo-Controlled Trial